HIT Consultant

DECEMBER 16, 2024

At the core of Promise Bios success is its proprietary PROMISE (Protein Modification Integrated Search Engine) platform, developed by Co-Founder & CTO Dr. Assaf Kacen. Yifat Merbls lab at the Weizmann Institute and published in Nature Biotechnology in 2023, allows high-throughput profiling of dozens of PTMs using mass spectrometry.

Biotechnology 52

Biotechnology Integration Life Sciences 52

HIT Consultant

OCTOBER 13, 2022

What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,

Biotechnology 98

Biotechnology Regulations Prevention Integration 98

GoMoHealth

DECEMBER 9, 2021

Trajectory’s clients span industry segments of consumer health and wellness, healthcare providers and payers, medical practices/integrative health and wellness, skin care and beauty, including Atlantic Health System, CareOne, IDCare, NeoStrata, Perma Blend, Progyny, Sylvania and Tower Health.

Biotechnology 100

Biotechnology Life Sciences Integration Hospitals 100

HIT Consultant

AUGUST 13, 2024

This collaboration marks a significant step forward in the integration of AI and biotechnology for drug discovery and development. The company’s investment in Transcell further solidifies its position as a leader in the healthcare and life sciences industry.

Life Sciences 52

Life Sciences Biotechnology Integration Healthcare 52

Cloud Blogs

MAY 18, 2021

Integrating AI and machine learning into the healthcare ecosystem allows for a variety of benefits, including automating administrative tasks, easing workflows, and analyzing large data sets to deliver better healthcare faster, and at a lower cost.

Biotechnology 91

Biotechnology Life Sciences Healthcare Innovation Healthcare 91

HIT Consultant

JULY 19, 2024

Jinyong Lee, CEO & Co-Founder of Kryptos Biotechnologies Most of us have been tested for COVID-19 over the past few years. For point-of-care testing, miniaturized integrated systems using disease-specific cartridges incorporating microfluidics technology have been developed. Can PCR be made less expensive?

Biotechnology 98

Biotechnology Integration Life Sciences 98

HIT Consultant

JANUARY 28, 2022

Benchling , pioneer of the R&D Cloud powering the biotechnology industry appoints Paul Robson, a cloud veteran as President of Field Operations and Elena Donio, the former CEO of Axiom and President of Concur, to its board, as a director and compensation committee chair. . – Leah Ray , Chief Customer Officer.

Biotechnology 98

Biotechnology Life Sciences Private Practices Pharmaceuticals 98

HIT Consultant

JUNE 30, 2022

The new research reveals perspectives on the life sciences industry based on an extensive analysis of over 300 M&A deals made by the top 30 biopharma companies between 2010–2021. However, the pace of innovation in life sciences is at an all-time high. Inorganic Growth Strategy.

Life Sciences 52

Life Sciences Biotechnology Integration 52

HIT Consultant

MAY 30, 2023

Sonia Fischer, Customer Integrations Manager, IQVIA In the age of biotechnology , biosample collection has become an essential part of medical research. Ensuring Long Term Compliance and Patient Autonomy Biosample collection is an integral part of medical research.

Biotechnology 98

Biotechnology Integration Prevention Patient Experience 98

HIT Consultant

JANUARY 11, 2022

What You Should Know: – PostEra , a biotechnology company specializing in machine learning for preclinical drug discovery, today announced $24M in equity financing to accelerate medicinal chemistry and bring new cures to patients.

Biotechnology 52

Biotechnology Integration Life Sciences 52

HIT Consultant

DECEMBER 6, 2022

of Integrated Pain Solutions is being conducted to understand the link between functional motion and incapacitating back and leg pain in patients being treated with Nevro Corp. A recent clinical study led by medical director Gladstone C. McDowell II, M.D., HFX Spinal Cord Stimulation. About Frank Fornari, Ph.D. Frank Fornari, Ph.D.,

Doctors 52

Doctors Life Sciences Biotechnology Rehabilitation 52

HIT Consultant

OCTOBER 26, 2023

What You Should Know: – Georgiamune , a privately held, clinical stage biotechnology company, and Verily , an Alphabet precision health technology company forms a strategic partnership to advance novel therapeutics for patients with cancer.

Biotechnology 52

Biotechnology Health Technology Integration Life Sciences 52

HIT Consultant

OCTOBER 22, 2021

appoints Holly May was appointed Executive Vice President and Global Chief Human Resources Officer, and Anita Allemand was appointed Chief Transformation and Integration Officer. Integrity Applications, Inc. Rebus Biosystems , an Illumina Ventures-backed life science technology company creating?revolutionary?tools?to?advance

Biotechnology 52

Biotechnology Life Sciences Accountability Accountable Care 52

HIT Consultant

DECEMBER 5, 2022

The National Center for Biotechnology Information (NCBI) reports that decentralized models recruited participants three times faster than the traditional model. Rachael’s expertise includes leading business development initiatives and integrated marketing platforms while building departments to scale.

Biotechnology 52

Biotechnology Pharmaceuticals Integration Life Sciences 52

HIT Consultant

JUNE 19, 2024

Athos”), a clinical-stage biotechnology company, has chosen Vultr Cloud GPU to run its AI model training, tuning, and inference. By leveraging Vultr’s platform, Athos seamlessly scales their AI analytical capabilities, including their data lake and integrative deep machine learning engine.

Biotechnology 111

Biotechnology Regulations Integration Hospitals 111

HIT Consultant

NOVEMBER 13, 2024

Genesis Therapeutics Partners with NVIDIA to Advance AI-Driven Drug Discovery Genesis Therapeutics, an AI-focused biotechnology company headquartered in Burlingame, CA, is revolutionizing small molecule drug discovery through its proprietary generative and predictive AI platform, **GEMS (Genesis Exploration of Molecular Space)**.

Biotechnology 98

Biotechnology Life Sciences Integration 98